According to the World Health Organization (WHO), about 10 million people are affected by tuberculosis, each year. Further, tuberculosis is the leading cause of death from a single infectious agent, ranking above HIV/AIDS. The rise in initiatives by governments and independent organizations to control the spread of tuberculosis is also contributing to the growth of the global tuberculosis diagnostics market. An increase in expenditure on R&D activities for the development of novel tuberculosis diagnostic procedures will be a major factor for the growth of the tuberculosis diagnostics market growth in the forecast period. However, the high cost associated with the Tuberculosis testing procedure may hamper the market growth.